Drug intelligence / Profile preview

egg yolk immunoglobulin

Development stage
Unknown
Lead developer
Third Xiangya Hospital, Central South University
Modality
Antibody-Based Therapeutics
Administration
Oral
01

Overview

Egg yolk immunoglobulin (IgY) is a polyclonal antibody biologic derived from the eggs of hens immunized against *Helicobacter pylori*. It is utilized as an oral passive immunotherapy to treat *H. pylori* infections, particularly as an adjuvant in rescue therapy for patients who have failed standard antibiotic treatments. The mechanism involves the specific binding of IgY to *H. pylori* cell surface components, which inhibits bacterial colonization and adhesion to the gastric mucosa, thereby facilitating the clearance of the pathogen. Research conducted at The Third Xiangya Hospital of Central South University has demonstrated that when combined with bismuth-based quadruple therapy, IgY can improve symptomatic relief and reduce the incidence of adverse reactions compared to standard therapy alone. It is often categorized as a nutraceutical or nutritional supplement but is evaluated in clinical settings for its therapeutic efficacy in gastrointestinal disease management.

Other names
egg yolk antibodyIgYanti-Helicobacter pylori egg yolk immunoglobulinYolk antibody
02

Targets

Helicobacter pylori cell-surface antigensUrease

Beyond the preview

Go deeper on egg yolk immunoglobulin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on egg yolk immunoglobulin.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call